NASDAQ:PTH', 'PowerShares DWA Healthcare Momentum ETF', 'http://weeklyregister.com/weekly-register-logo.png');

What’s PowerShares DWA Healthcare Momentum ETF (PTH) Upside After Forming Bullish Wedge Up?

December 7, 2017 - By Darrin Black

The stock of PowerShares DWA Healthcare Momentum ETF (PTH) formed an up wedge with $72.39 target or 5.00 % above today’s $68.94 share price. The 9 months wedge indicates low risk for the $164.30M company. If the $72.39 price target is reached, the company will be worth $8.22 million more.
Rising wedges, especially for downward breakouts are tricky moments to trade. Investors must be aware that the break even failure rate for up or down breakouts is: 8% and 24%. The average rise is 28% and the decline is 14%. Wedges has high throwback and pullback rate: 73%, 63% and the percent of wedges meeting target is not more than 50%.

The ETF increased 2.67% or $1.79 during the last trading session, reaching $68.94. About 12,680 shares traded. PowerShares DWA Healthcare Momentum ETF (NASDAQ:PTH) has risen 22.34% since December 8, 2016 and is uptrending. It has outperformed by 5.64% the S&P500.

More notable recent PowerShares DWA Healthcare Momentum ETF (NASDAQ:PTH) news were published by: Seekingalpha.com which released: “Trumpcare Collapse Fuels Rally In Healthcare Stocks And ETFs” on March 29, 2017, also Nasdaq.com with their article: “Mid-Day ETF Update: ETFs, Stocks Mixed as Street Digests Q3 GDP Data, Yellen …” published on November 29, 2017, Nasdaq.com published: “Mid-Day ETF Update: ETFs, Stocks Slump as Flynn Testimony Triggers Anew …” on December 01, 2017. More interesting news about PowerShares DWA Healthcare Momentum ETF (NASDAQ:PTH) were released by: Benzinga.com and their article: “Heaps Of Healthy Health Care ETFs” published on October 06, 2017 as well as Nasdaq.com‘s news article titled: “Mid-Day ETF Update: ETFs, US Stocks Extend Gains As Congress Moves to Prevent …” with publication date: December 07, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.